]. Chronic obstructive pulmonary disease (COPD) is a worldwide leading cause of morbidity and mortality and associated with great individual, societal and economic burden [1]. Dyspnoea is the threatening cardinal symptom and related to a worse course of COPD, including drastic reductions in quality of life and even increased mortality risk [2, 3]. Dyspnoea is a multi-dimensional subjective experience that encompasses not only the perception of sensory signals (dyspnoea intensity), but also important immediate and long-term affective aspects (dyspnoea unpleasantness, dyspnoea anxiety, suffering) [2-4]. In many patients, dyspnoea can be persistent, despite optimal treatment efforts, which was recently termed "chronic breathlessness syndrome" [5]. Notwithstanding, reducing dyspnoea is a major treatment goal in COPD [6] and neglecting it has previously been discussed in a thought-provoking article in this journal as a potential violation of human rights [7]. In addition to the prominent pulmonary manifestations of COPD, patients often suffer from various extrapulmonary symptoms and comorbidities, which further add to the burden of the disease [8, 9]. Among these, psychological symptoms, such as anxiety and depression, are very common in COPD and related to various negative health outcomes, including greater dyspnoea [10-12]. For example, COPD patients with high anxiety levels report more dyspnoea during everyday life [13], during pulmonary rehabilitation [14], and during resistive loaded breathing tests [15] compared to patients with low anxiety levels. Alarmingly, comorbid psychological symptoms remain undiagnosed in the majority of COPD patients and, thus, untreated [11]. But how can psychological symptoms such as anxiety lead to greater dyspnoea in COPD patients? Although several potential physiological and behavioural pathways have been suggested [11, 16], respective knowledge remains still limited. Some authors have emphasised that after repeated aversive experiences of dyspnoea, patients develop fear and anxiety and subsequently avoid respective dyspnoea-related situations and contexts such as physical activities. This maladaptive avoidance behaviour can result in progressive deconditioning and physiological deterioration, which further increases dyspnoea at even lower activity levels and contributes to disease progression [17, 18]. Following successful models in other symptom domains, such as the fear-avoidance model of chronic pain [19], especially the anxious expectation or